Cogent Biosciences (COGT) Preferred Dividend Payments (2017 - 2018)
Cogent Biosciences (COGT) recorded quarterly Preferred Dividend Payments of $16000.0 in Q1 2018, little changed quarter-over-quarter from $16000.0 in Q4 2017, and little changed on a YoY basis from $16000.0 in Q1 2017.
Cogent Biosciences (COGT) Preferred Dividend Payments (2017 - 2018) Analysis & Trends
Cogent Biosciences' Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at $16000.0 for Q1 2018.
- In Q1 2018, Preferred Dividend Payments changed 0.0% year-over-year to $16000.0; the TTM figure through Dec 2018 stood at $16000.0 (down 75.38% YoY), while the FY2018 annual figure was $16000.0, down 75.38% from the prior year.
- Preferred Dividend Payments was $16000.0 for Q1 2018 at Cogent Biosciences, roughly flat from $16000.0 in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $17000.0 in Q2 2017 to a low of $16000.0 in Q1 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Cogent Biosciences | 5.19 Bn | 4.32 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 16,000.00 |
| Dec 31, 2017 | 16,000.00 |
| Sep 30, 2017 | 16,000.00 |
| Jun 30, 2017 | 17,000.00 |
| Mar 31, 2017 | 16,000.00 |